Analysts’ Views On Supernus Pharmaceuticals Inc. (SUPN)

PTGX

Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) finished Wednesday with a subtraction of -$2.38 to close at $30.53, a downside of -7.23 percent. An average of 628,100 shares of common stock have been traded in the last five days. There was a fall of -$1.00 in the past week, and it reached a new high 22 times over […]